1.Scottish Intercollegiate Guidelines Network.SIGN 50：A guideline developer’s handbook Edinburgh：SIGN，2014.

2.Richard RM，Shiffman RN.Clinical practice guideline development manual：A quality-driven approach for translating evidence into action.Otolaryngol Head Neck Surgery，2009，140（6 Suppl 1）：S1-43.

3.Institute of Medicine of the National Academies.Knowing What Works in Health Care.A Roadmap for the Nation.Washington，DC：The National Academies Press，2008.

4.National Health and Medical Research Council.A guide to the development，implementation and evaluation of clinical practice guidelines.Canberra：Commonwealth of Australia，1998.

5.Council of Europe.Developing a methodology for drawing up guidelines on best medical practices.Recommendation Rec（2001）13.Strasbourg：COE，2001

6.Chen SJ，Zhou GB，Zhang XW，et al.From an old remedy to a magic bullet：molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia.Blood，2011，117（24）：6425-6437.

7.Zhang XW，Yan XJ，Zhou ZR，et al.Arsenic trioxide controls the fate of the PML-RA Ralpha oncoprotein by directly blinding PML.Science，2010，328（5975）：240-243.

8.Liu GT.The anti-virus and hepatoprotective effect of Bicyclol and its mechanism of action.Chin J New drugs，2001，10（5）：325-327.

9.Liu GT.Perspective of the modernization of traditional Chinese medicine.Chin J Integr Tradit West Med，2001，21（1）：3-4.

10.Canter P H，Lee H S，Ernst E.A systematic review of randomized clinical trials of Tripterygium wilfordii for rheumatoid arthritis.Phytomedicine，2006，13（5）：371-377.

11.中国中西医结合学会普通外科专业委员会．重症急性胰腺炎中西医结合诊治指南（2014年，天津）．中国中西医结合外科杂志，2014，20（4）：460-461.